Fedorova, Olga V
- National Institute On Aging (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,241
- Sustained Excellence
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2016 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$3.7M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,241
By linked amount among FY2023 PIs
Earliest Year Loaded
2016
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Fedorova, Olga V as a PI. Multi-PI records show the full award amount for context.
- 1ZIAAG000846-08ZIAContact PIExploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease$2.2Maward amount
- 1ZIAAG000609-31ZIAContact PISodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging$1.5Maward amount
Award organization
Organizations that administered FY2023 awards listing Fedorova, Olga V as a PI.
FY2023 award administered by National Institute On Aging ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2016First NIH AwardNational Institute On Aging
- 2016$500K Cumulative Funding
- 2016$1M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #3888
- 2016Entered Top 25% NationallyRanked #3888
- 2017$2M Cumulative Funding
- 2017$5M Cumulative Funding
- 2017Entered Top 10% NationallyRanked #862
- 2017Entered Top 5% NationallyRanked #862
- 2019$10M Cumulative Funding